In 2023, Japan's import of insulin stood at 12.13 thousand kilograms. Forecasted import values indicate a steady increase, rising from 12.59 thousand kilograms in 2024 to 14.54 thousand kilograms by 2028. This represents a compound annual growth rate (CAGR) of approximately 3.6% over the five-year period. Year-on-year growth remains relatively consistent, evidencing Japan's ongoing reliance on imported insulin.
Future trends to monitor include Japan's healthcare advancements and domestic production capabilities, which might influence import volumes. Additionally, shifts in medical policies or global insulin production could significantly impact Japan’s insulin import landscape.
